Loading…

The Expression of Both Peroxisome Proliferator-Activated Receptor Delta and Cyclooxygenase-2 in Tissues Is Associated with Poor Prognosis in Colorectal Cancer Patients

Background The role of peroxisome proliferator-activated receptor delta (PPAR δ) in the development and progression of colorectal cancer (CRC) remains controversial. Aims We investigated the impact of PPAR δ expression in tissues on liver metastasis of CRC. Methods We analyzed samples of primary CRC...

Full description

Saved in:
Bibliographic Details
Published in:Digestive diseases and sciences 2011-04, Vol.56 (4), p.1194-1200
Main Authors: Yoshinaga, Masahiro, Taki, Kentaro, Somada, Shinichi, Sakiyama, Yumiko, Kubo, Norihiko, Kaku, Toyoma, Tsuruta, Satoru, Kusumoto, Tetsuya, Sakai, Hironori, Nakamura, Kazuhiko, Takayanagi, Ryoichi, Muto, Yoichi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The role of peroxisome proliferator-activated receptor delta (PPAR δ) in the development and progression of colorectal cancer (CRC) remains controversial. Aims We investigated the impact of PPAR δ expression in tissues on liver metastasis of CRC. Methods We analyzed samples of primary CRC and matched normal adjacent tissues from 52 patients for the expression of PPAR δ, cyclooxygenase (COX)-2, vascular endothelial growth factor (VEGF)-A, and CXC chemokine receptor 4 (CXCR4). Correlations of the molecules expressions with clinical characteristics and prognosis of patients were studied. Results The number of patients positive for PPAR δ, COX-2, CXCR4, and VEGF-A was 25, 33, 18, and 19, respectively. Among the PPAR δ (+)/COX-2 (+), PPAR δ (−)/COX-2 (+), PPAR δ (+)/COX-2 (−), and PPAR δ (−)/COX-2 (−) patient groups, PPAR δ (+)/COX-2 (+) patients had the highest incidence of liver metastasis ( p  
ISSN:0163-2116
1573-2568
DOI:10.1007/s10620-010-1389-9